ARMP Armata Pharmaceuticals, Inc.

Develops and commercializes novel bacteriophage-based therapeutics

$5.00  +0.06 (1.22%)
As of 12/07/2021 13:35:08 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  08/20/2015
Outstanding shares:  27,086,299
Average volume:  65,327
Market cap:   $121,888,346
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    04216R102
ISIN:        US04216R1023
Valuation   (See tab for details)
PE ratio:   -5.64
PB ratio:   5.19
PS ratio:   72.80
Return on equity:   -99.90%
Net income %:   -1,417.41%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy